Dexmedetomidine Completed Phase 4 Trials for Ropivacaine (DB00296)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0050052 (Dexmedetomidine) | Completed | 4 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT04398589 | The Effect of Dexmedetomidine for Suprascapular Nerve Block With Axillary Nerve Block | Treatment |